PRELIMINARY COST-EFFECTIVENESS ANALYSIS OF PROTON BEAM THERAPY IN PATIENTS WITH HEPATOCELLULAR CARCINOMA IN JAPAN

被引：0
|
作者：
Moriwaki, K. [1 ]
Katoh, N. [2 ]
Hayashi, H. [2 ]
Miyakoshi, T. [2 ]
Terashima, K. [3 ]
Murayama, S. [4 ]
Suzuki, M. [5 ]
Okumura, T. [6 ]
Araya, M. [7 ]
Hojo, H. [8 ]
Iwata, H. [9 ]
机构：
[1] Ritsumeikan Univ, Kyoto 26, Japan
[2] Hokkaido Univ Hosp, Sapporo, Hokkaido, Japan
[3] Hyogo Ion Beam Med Ctr, Tatsuno, Hyogo, Japan
[4] Shizuoka Canc Ctr, Shizuoka, Japan
[5] Southern Tohoku Proton Therapy Ctr, Fukushima, Japan
[6] Univ Tsukuba, Ibaraki, Japan
[7] Aizawa Hosp, Nagano, Japan
[8] Natl Canc Ctr Hosp East, Chiba, Japan
[9] Nagoya City Univ, West Med Ctr, Nagoya, Aichi, Japan
来源：
VALUE IN HEALTH | 2022年 / 25卷 / 07期
关键词：
D O I：
暂无
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
EE361
引用
收藏
页码：S406 / S406
页数：1
相关论文
共 50 条
  • [1] DEVELOPMENT OF AN ECONOMIC MODEL TO ASSESS THE COST-EFFECTIVENESS OF PROTON BEAM THERAPY IN PATIENTS WITH HEPATOCELLULAR CARCINOMA IN JAPAN
    Hagino, Y.
    Moriwaki, K.
    VALUE IN HEALTH, 2018, 21 : S15 - S15
  • [2] Analysis of the cost-effectiveness of proton beam therapy for unresectable pancreatic cancer in Japan
    Hiroshima, Yuichi
    Kondo, Masahide
    Sawada, Takuya
    Hoshi, Shu-Ling
    Okubo, Reiko
    Iizumi, Takashi
    Numajiri, Haruko
    Okumura, Toshiyuki
    Sakurai, Hideyuki
    CANCER MEDICINE, 2023, 12 (20): : 20450 - 20458
  • [3] Cost-effectiveness analysis for multi adverse events of proton beam therapy for pediatric medulloblastoma in Japan
    Yoshimura, Takaaki
    Morii, Yasuhiro
    Tamori, Honoka
    Kita, Ryuki
    Hashimoto, Takayuki
    Aoyama, Hidefumi
    Ogasawara, Katsuhiko
    Journal of Radiation Research, 66 (01): : 31 - 38
  • [4] Cost-effectiveness analysis for multi adverse events of proton beam therapy for pediatric medulloblastoma in Japan
    Yoshimura, Takaaki
    Morii, Yasuhiro
    Tamori, Honoka
    Kita, Ryuki
    Hashimoto, Takayuki
    Aoyama, Hidefumi
    Ogasawara, Katsuhiko
    JOURNAL OF RADIATION RESEARCH, 2024,
  • [5] Cost-effectiveness analysis using lifetime attributable risk of proton beam therapy for pediatric medulloblastoma in Japan
    Yoshimura, Takaaki
    Tamori, Honoka
    Morii, Yasuhiro
    Hashimoto, Takayuki
    Shimizu, Shinichi
    Ogasawara, Katsuhiko
    JOURNAL OF RADIATION RESEARCH, 2021, 62 (06) : 1022 - 1028
  • [6] Analysis of the cost-effectiveness of proton beam therapy for unresectable pancreatic cancer
    Hiroshima, Y.
    Kondo, M.
    Sawada, T.
    Hoshi, S.
    Okubo, R.
    Iizumi, T.
    Numajiri, H.
    Okumura, T.
    Sakurai, H.
    RADIOTHERAPY AND ONCOLOGY, 2023, 182 : S47 - S48
  • [7] Cabozantinib for patients with advanced hepatocellular carcinoma: a cost-effectiveness analysis
    Shlomai, Amir
    Leshno, Moshe
    Goldstein, Daniel A.
    THERAPEUTIC ADVANCES IN GASTROENTEROLOGY, 2019, 12
  • [8] COST-EFFECTIVENESS ANALYSIS OF REGORAFENIB IN PATIENTS WITH ADVANCED HEPATOCELLULAR CARCINOMA
    Kim, J.
    Hay, J. W.
    VALUE IN HEALTH, 2018, 21 : S29 - S29
  • [9] Cost-Effectiveness of Proton Beam Therapy for Intraocular Melanoma
    Moriarty, James P.
    Borah, Bijan J.
    Foote, Robert L.
    Pulido, Jose S.
    Shah, Nilay D.
    PLOS ONE, 2015, 10 (05):
  • [10] Cost-effectiveness of Proton Beam Therapy for Oncologic Management
    Verma, Vivek
    Mishra, Mark V.
    Simone, Charles B., II
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2018, 101 (02): : E20 - E20
12345